BioCatalystWatch
RCKTWorkspace / RCKT / OverviewCompany library
ROCKET PHARMACEUTICALS, INC. logo

ROCKET PHARMACEUTICALS, INC.

ROCKET PHARMACEUTICALS, INC. (RCKT)

Website

Price
Market cap
Next catalystComplete pivotal trial dosing by mid-2027RP-A501 — pivotal Phase 2 · Dosing completionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

RP-A501

LAMP2B transgene

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

RP-A601

PKP2 transgene

PreINDP1P2P3FilingApproved

Approved / commercial

ITGB2 transgene

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

PGK-coRPK-WPRE cassette

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

RCKT PR & News

PR & News

RCKT SEC archive